Brief: Lineage Cell Therapeutics Inc Says VAC2 Demonstrated Remarkably Potent Induction Of Immune Responses In All Patients Dosed To Date

Lineage Cell Therapeutics

13/10/2020 14:15

Oct 13 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS INC - VAC2 DEMONSTRATED
REMARKABLY
POTENT INDUCTION OF IMMUNE RESPONSES IN ALL PATIENTS DOSED TO
DATE
    * LINEAGE CELL - POST COMPLETION OF ONGOING VAC2 CLINICAL
STUDY IN
NSCLC, TO SEEK TO EVALUATE VAC2 WITH THERAPIES CONSIDERED
BIOLOGICALLY COMPLEMENTARY TO VAC2
    * LINEAGE CELL THERAPEUTICS INC - VAC2 THERAPY WAS SAFE AND
WELL
TOLERATED IN ALL PATIENTS

Source text for Eikon:  ID:nBw79DW5Ya 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))